Umbilical Cord Blood Collection and Processing for Pre-clinical Cardiac Regeneration

Overview

About this study

The purpose of this study is to serve as the foundation to determine if a larger clinical study may be beneficial with the goal of establishing cord blood as a cell source to treat congenital heart disease for unhealthy babies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:    

  • Patients age 18 and older in their second or third trimester of normal pregnancy will be eligible to participate in this research study.   

Exclusion Criteria:   

  • Abnormal pregnancy that may include birth defects of the fetus, maternal complications with the placenta or umbilical cord anatomy, and/or any complications during the birthing process.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Susana Cantero Peral, M.D., Ph.D.

Open for enrollment

Contact information:

Lori Riess CCRP

7787730

riess.lori@mayo.edu

Eau Claire, Wis.

Mayo Clinic principal investigator

Blenda Yun, M.D.

Open for enrollment

Contact information:

Holly Hennlich

7154648172

Hennlich.Holly@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20320962

Mayo Clinic Footer